Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.

Autor: McPhail S; National Disease Registration Service, NHS England, Leeds, UK., Barclay ME; Epidemiology of Cancer Healthcare & Outcomes, Department of Behavioural Science & Health, Institute of Epidemiology & Health Care, University College London, London, UK., Johnson SA; Cancer Intelligence, Cancer Research UK, London, UK., Swann R; National Disease Registration Service, NHS England, Leeds, UK; Cancer Intelligence, Cancer Research UK, London, UK., Alvi R; Department of Epidemiology and Performance Measurement, Saskatchewan Cancer Agency, Saskatoon, SK, Canada., Barisic A; Ontario Health (Cancer Care Ontario), Toronto, ON, Canada., Bucher O; Department of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, MB, Canada., Creighton N; Cancer Institute NSW, St Leonards, NSW, Australia., Denny CA; Public Health Scotland, Edinburgh, UK., Dewar RA; Nova Scotia Health Cancer Care Program, Halifax, NS, Canada., Donnelly DW; Northern Ireland Cancer Registry, Queen's University Belfast, Belfast, UK., Dowden JJ; Provincial Cancer Care Program, Eastern Health, St John's, NL, Canada., Downie L; Public Health Scotland, Edinburgh, UK., Finn N; Victorian Cancer Registry, Cancer Council Victoria, Melbourne, VIC, Australia; Cancer Support, Treatment and Research, Department of Health, Melbourne, VIC, Australia., Gavin AT; Northern Ireland Cancer Registry, Queen's University Belfast, Belfast, UK., Habbous S; Ontario Health (Cancer Care Ontario), Toronto, ON, Canada., Huws DW; Welsh Cancer Intelligence and Surveillance Unit, Public Health Data, Knowledge and Research Directorate, Public Health Wales, Cardiff, UK; Population Data Science, Swansea University Medical School, Swansea, UK., May L; Welsh Cancer Intelligence and Surveillance Unit, Public Health Data, Knowledge and Research Directorate, Public Health Wales, Cardiff, UK., McClure CA; Prince Edward Island Cancer Registry, Queen Elizabeth Hospital, Charlottetown, PE, Canada., Møller B; Cancer Registry of Norway, Oslo, Norway., Musto G; Department of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, MB, Canada., Nilssen Y; Cancer Registry of Norway, Oslo, Norway., Saint-Jacques N; Nova Scotia Health Cancer Care Program, Halifax, NS, Canada., Sarker S; Department of Epidemiology and Performance Measurement, Saskatchewan Cancer Agency, Saskatoon, SK, Canada., Shack L; Cancer Advanced Analytics, Cancer Research & Analytics, Cancer Care Alberta, Alberta Health Services, Calgary, AB, Canada., Tian X; Cancer Advanced Analytics, Cancer Research & Analytics, Cancer Care Alberta, Alberta Health Services, Calgary, AB, Canada., Thomas RJS; University of Melbourne, Parkville, VIC, Australia., Thomson CS; Public Health Scotland, Edinburgh, UK., Wang H; Provincial Cancer Care Program, Eastern Health, St John's, NL, Canada., Woods RR; Cancer Control Research, BC Cancer, Vancouver, BC, Canada., You H; Cancer Institute NSW, St Leonards, NSW, Australia., Lyratzopoulos G; National Disease Registration Service, NHS England, Leeds, UK; Epidemiology of Cancer Healthcare & Outcomes, Department of Behavioural Science & Health, Institute of Epidemiology & Health Care, University College London, London, UK. Electronic address: y.lyratzopoulos@ucl.ac.uk.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2024 Mar; Vol. 25 (3), pp. 338-351.

Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study.

Autor: McPhail S; National Disease Registration Service, NHS Digital, Leeds, UK., Swann R; National Disease Registration Service, NHS Digital, Leeds, UK; Cancer Research UK, London, UK., Johnson SA; Cancer Research UK, London, UK., Barclay ME; Epidemiology of Cancer Healthcare and Outcomes, Department of Behavioural Science and Health, Institute of Epidemiology and Health Care (IEHC), University College London, London, UK., Abd Elkader H; Cancer Society of New Zealand, Wellington, New Zealand., Alvi R; Department of Epidemiology and Performance Measurement, Saskatchewan Cancer Agency, Saskatoon, SK, Canada., Barisic A; Ontario Health (Cancer Care Ontario), Toronto, ON, Canada., Bucher O; Department of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, MB, Canada., Clark GRC; Public Health Scotland, Edinburgh, UK., Creighton N; Cancer Institute NSW, St Leonards, NSW, Australia., Danckert B; Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark., Denny CA; Public Health Scotland, Edinburgh, UK., Donnelly DW; Northern Ireland Cancer Registry, Queen's University Belfast, Belfast, UK., Dowden JJ; Provincial Cancer Care Program, Eastern Health, St John's, NL, Canada., Finn N; Victorian Cancer Registry, Cancer Council Victoria, Melbourne, VIC, Australia; Cancer Support, Treatment and Research, Department of Health, Melbourne, VIC, Australia., Fox CR; Northern Ireland Cancer Registry, Queen's University Belfast, Belfast, UK., Fung S; Canadian Partnership against Cancer, Toronto, ON, Canada., Gavin AT; Northern Ireland Cancer Registry, Queen's University Belfast, Belfast, UK., Gomez Navas E; Canadian Partnership against Cancer, Toronto, ON, Canada., Habbous S; Ontario Health (Cancer Care Ontario), Toronto, ON, Canada., Han J; Canadian Partnership against Cancer, Toronto, ON, Canada., Huws DW; Welsh Cancer Intelligence and Surveillance Unit, Public Health Data, Knowledge and Research Directorate, Public Health Wales, Cardiff, UK; Population Data Science, Swansea University Medical School, Swansea, UK., Jackson CGCA; Department of Medicine, Otago Medical School, University of Otago, Dunedin, New Zealand., Jensen H; Research Unit for General Practice, Aarhus University, Aarhus, Denmark., Kaposhi B; Surveillance and Reporting, Advanced Analytics, Cancer Care Alberta, Alberta Health Services, Edmonton., Kumar SE; New Brunswick Cancer Network, Department of Health, New Brunswick, Fredericton, NB, Canada., Little AL; Cancer Institute NSW, St Leonards, NSW, Australia., Lu S; Calgary, AB, Canada., McClure CA; Prince Edward Island Cancer Registry, Queen Elizabeth Hospital, Charlottetown, PE, Canada., Møller B; Cancer Registry of Norway, Oslo, Norway., Musto G; Department of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, MB, Canada., Nilssen Y; Cancer Registry of Norway, Oslo, Norway., Saint-Jacques N; Nova Scotia Health Cancer Care Program, Halifax, NS, Canada., Sarker S; Department of Epidemiology and Performance Measurement, Saskatchewan Cancer Agency, Saskatoon, SK, Canada., Te Marvelde L; Victorian Cancer Registry, Cancer Council Victoria, Melbourne, VIC, Australia., Thomas RS; Welsh Cancer Intelligence and Surveillance Unit, Public Health Data, Knowledge and Research Directorate, Public Health Wales, Cardiff, UK; Department of the Dean, Medicine Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, Australia., Thomas RJS; Welsh Cancer Intelligence and Surveillance Unit, Public Health Data, Knowledge and Research Directorate, Public Health Wales, Cardiff, UK; Department of the Dean, Medicine Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, Australia., Thomson CS; Public Health Scotland, Edinburgh, UK., Woods RR; Cancer Control Research, BC Cancer, Vancouver, BC, Canada., Zhang B; Health Analytics, Department of Health, Fredericton, NB, Canada., Lyratzopoulos G; National Disease Registration Service, NHS Digital, Leeds, UK; Epidemiology of Cancer Healthcare and Outcomes, Department of Behavioural Science and Health, Institute of Epidemiology and Health Care (IEHC), University College London, London, UK. Electronic address: y.lyratzopoulos@ucl.ac.uk.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2022 May; Vol. 23 (5), pp. 587-600. Date of Electronic Publication: 2022 Apr 06.

Factors Explaining Socio-Economic Inequalities in Survival from Colon Cancer: A Causal Mediation Analysis.

Autor: Afshar N; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia. Nina.Afshar@cancervic.org.au.; Cancer Health Services Research Unit, Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia., Dashti SG; Clinical Epidemiology and Biostatistics Unit, Murdoch Children's Research Institute, Parkville, Victoria, Australia., Te Marvelde L; Victorian Cancer Registry, Cancer Council Victoria, Melbourne, Victoria, Australia., Blakely T; Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia., Haydon A; Department of Medical Oncology, Alfred Hospital, Melbourne, Victoria, Australia., White VM; School of Psychology, Deakin University, Burwood, Victoria, Australia.; Centre for Behavioural Research in Cancer, Cancer Council Victoria, Melbourne, Victoria, Australia., Emery JD; Cancer in Primary Care Research Group, Department of General Practice, University of Melbourne, Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia., Bergin RJ; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Cancer in Primary Care Research Group, Department of General Practice, University of Melbourne, Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia., Whitfield K; Cancer Strategy and Development, Department of Health and Human Services, Melbourne, Victoria, Australia., Thomas RJS; Cancer Strategy and Development, Department of Health and Human Services, Melbourne, Victoria, Australia., Giles GG; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia., Milne RL; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia., English DR; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.

Publikováno v: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2021 Oct; Vol. 30 (10), pp. 1807-1815. Date of Electronic Publication: 2021 Jul 16.

Optimal Cancer Care for Aboriginal and Torres Strait Islander People: A Shared Approach to System Level Change.

Autor: Chynoweth J; Cancer Australia, Surry Hills, NSW, Australia., McCambridge MM; Cancer Australia, Surry Hills, NSW, Australia., Zorbas HM; Cancer Australia, Surry Hills, NSW, Australia., Elston JK; Monash University, Clayton, VIC, Australia., Thomas RJS; University of Melbourne, Parkville, VIC, Australia., Glasson WJH; Terrace Eye Centre, Brisbane, QLD, Australia., Coutts JM; Cancer Australia, Surry Hills, NSW, Australia., Daveson BA; Cancer Australia, Surry Hills, NSW, Australia., Whitfield KM; Department of Health and Human Services, Melbourne, VIC, Australia.

Publikováno v: JCO global oncology [JCO Glob Oncol] 2020 Feb; Vol. 6, pp. 108-114.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.